DadFinStart your free week
DadFin › Stocks › Healthcare › MEDP

Medpace Holdings, Inc. (MEDP) stock score

Healthcare · Diagnostics & Research · United States

$612.05 ▲ +1.55% today

85.4
Dad Score, out of 100
strong

Medpace Holdings, Inc. (MEDP) is a Diagnostics & Research company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 85.4 out of 100 on the Dad Score, a strong reading that places the business ahead of 85% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #127 of 974. Its strongest axes are quality, growth and price action.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Average
Quality
Strong
Growth
Strong
Price action
Above average
Risk
Strong
Conviction
Strong
Liquidity
Strong
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)35.2×
P/E (forward)31.0×
Dividend yield0.00%
Return on capital85.9%
Operating margin20.8%
Revenue growth (YoY)+20.0%
FCF yield4.2%
Net debt / EBITDA-0.59×
Piotroski F-Score6 / 9
52-week change+13.0%
Market cap$16.7B
Next earningsOct 21, 2026

What subscribers see on MEDP

Start your free weekSubscriber? Open the full research →

Diagnostics & Research peers

StockCompanyDad ScoreBandMarket cap
TMOThermo Fisher Scientific Inc.77.0good$242.1B
DHRDanaher Corporation79.6good$150.5B
NTRANatera, Inc.86.1strong$59.1B
AAgilent Technologies, Inc.79.9good$47.3B
IQVIQVIA Holdings Inc.82.3good$42.5B
WATWaters Corporation78.8good$41.7B
ILMNIllumina, Inc.35.1weak$41.2B
IDXXIDEXX Laboratories, Inc.90.1strong$40.9B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.